📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Celerion

1.1 - Company Overview

Celerion Logo

Celerion

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of early clinical research and Applied Translational Medicine, translating research discoveries into knowledge of drug action in humans to support early development decisions. Services include bioanalytical sciences for small and large molecules; clinical development (safety, PK/PD); data management and biometrics; global drug development (regulatory, project management); EDC; and eTMF via secure, DIA-formatted portal.

Products and services

  • Clinical Development: Offers integrated services including medical expertise, clinical operations, and scientific excellence for early-stage drug development, focusing on safety assessments and pharmacokinetics/pharmacodynamics studies to support early development decisions
  • Bioanalytical Sciences: Celerion's bioanalytical laboratory conducts advanced-scale robust data analysis for small and large molecules across all drug development phases, emphasizing design, execution, and analysis activities
  • Data Management and Biometrics: Delivers technology-enabled comprehensive data management, biostatistics, clinical monitoring, and pharmacokinetic evaluations, leveraging the latest operational concepts and technologies for early-stage drug development

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Celerion

Continuum Clinical Logo

Continuum Clinical

HQ: United States Website
  • Description: Provider of Health Economics and Outcomes Research services and clinical trial engagement solutions, including the MERIS Total Engagement suite for participant and site support with real-time performance data; patient recruitment campaigns; Global Site Solutions; study/site support; retention solutions; and patient advocacy and diversity & inclusion services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Continuum Clinical company profile →
Resolian Logo

Resolian

HQ: United States Website
  • Description: Provider of multinational bioanalytical CRO services focused on medication metabolism and pharmacokinetics for small and big compounds.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Resolian company profile →
QPS Logo

QPS

HQ: United States Website
  • Description: Provider of GLP/GCP-compliant contract research services spanning discovery, preclinical and clinical drug development, including neuropharmacology, DMPK, toxicology, bioanalysis, translational medicine, and clinical development support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full QPS company profile →
Envigo Logo

Envigo

HQ: United Kingdom Website
  • Description: Provider of essential products and research services to pharmaceutical, crop protection, and chemical companies, as well as universities, governments, and other research organizations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Envigo company profile →
Gubra Logo

Gubra

HQ: Denmark Website
  • Description: Provider of pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs focused on the metabolic space, including obesity, diabetes, NASH, and diabetic complications, with specialization in in vivo pharmacology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gubra company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Celerion

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Celerion

2.2 - Growth funds investing in similar companies to Celerion

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Celerion

4.2 - Public trading comparable groups for Celerion

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Celerion

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Celerion

What does Celerion do?

Celerion is a provider of early clinical research and Applied Translational Medicine, translating research discoveries into knowledge of drug action in humans to support early development decisions. Services include bioanalytical sciences for small and large molecules; clinical development (safety, PK/PD); data management and biometrics; global drug development (regulatory, project management); EDC; and eTMF via secure, DIA-formatted portal.

Who are Celerion's competitors?

Celerion's competitors and similar companies include Continuum Clinical, Resolian, QPS, Envigo, and Gubra.

Where is Celerion headquartered?

Celerion is headquartered in United States.

How many employees does Celerion have?

Celerion has 1,000 employees 🔒.

When was Celerion founded?

Celerion was founded in 2010 🔒.

What sector and industry vertical is Celerion in?

Celerion is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Celerion

Who are the top strategic acquirers in Celerion's sector and industry

Top strategic M&A buyers and acquirers in Celerion's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Celerion?

Top strategic M&A buyers groups and sectors for Celerion include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Celerion's sector and industry vertical

Which are the top PE firms investing in Celerion's sector and industry vertical?

Top PE firms investing in Celerion's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Celerion's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Celerion's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Celerion's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Celerion include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Celerion's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Celerion?

The key public trading comparables and valuation benchmarks for Celerion include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Celerion for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Celerion with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Celerion's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Celerion with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Celerion's' sector and industry vertical?

Access recent funding rounds and capital raises in Celerion's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Celerion